Eli Lilly and Company, a major contributor to the IDF Life for a Child Programme (LFAC), recently announced an additional commitment of 780,000 vials of insulin to LFAC.
Lilly’s new commitment builds on the company’s previous donation of 800,000 vials of insulin over the past six years, which reached more than 14,000 children in approximately 34 countries. Over the next three years, Lilly will donate approximately 260,000 vials of insulin each year to Life for a Child. This commitment will allow LFAC to continue providing treatment for children in the countries where the programme currently operates and to increase the amount of insulin supplied for distribution.
"Lilly's donation of insulin offers continued hope to children and families in need who are trying to manage type 1 diabetes in very challenging conditions," said Dr Graham Ogle, LFAC General Manager.